Bioventures L. P. Bb

This profile gathers the share dealings of Bioventures L. P. Bb across 4 companies, led by Pharmasset Inc, Omrix Biopharmaceuticals, Inc. and Oscient Pharmaceuticals Corp. Over a trading history stretching from 18 October 2006 to 15 May 2009, the count stands at 53 filings.

On the open market, the record shows 1 purchase worth €1.8M and 40 sales worth €8.4M. On balance, insiders were net sellers of €6.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.

The latest filing, published on 29 May 2009, reports a transaction of €3,440 in Oscient Pharmaceuticals Corp. The clock since the last published purchase (4 May 2007) now reads 7,113 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.